Introduction
BCG (Bacillus Calmette-Guérin) is a form of immunotherapy used to treat non-muscle invasive bladder cancer (NMIBC). By stimulating the body’s immune system, BCG helps prevent cancer recurrence and progression, making it a highly effective treatment for this type of bladder cancer.
Purpose
- Treats non-muscle invasive bladder cancer (stages Ta, T1, and CIS).
- Reduces the risk of cancer recurrence and progression.
- Preserves bladder function while effectively managing cancer.
How It Works
BCG is a live, weakened strain of Mycobacterium bovis. When instilled into the bladder, it triggers an immune response that targets cancer cells, reducing their ability to grow and spread.
Usage
- Administered directly into the bladder through a catheter (intravesical therapy) once weekly for 6 weeks (induction phase).
- Maintenance therapy may follow with periodic treatments over several months to years, depending on individual response.
- Each session requires holding the medication in the bladder for approximately 2 hours before voiding.
Considerations
- Common side effects include bladder irritation, frequent urination, and mild flu-like symptoms.
- Rare but serious side effects include systemic infection; patients are monitored closely for signs of complications.
- Patients should avoid caffeine and excessive fluid intake on treatment days to minimize discomfort.
At Crossroads Urology
At Crossroads Urology, we specialize in administering BCG therapy as part of a comprehensive bladder cancer treatment plan. Our providers ensure patient comfort and safety while delivering this highly effective therapy.
Conclusion
BCG [Bacillus Calmette-Guérin] is a proven immunotherapy for managing non-muscle invasive bladder cancer, helping patients achieve excellent outcomes while preserving bladder function. Contact Crossroads Urology today to learn more about this life-saving treatment.